fbpx

< Back to Thought Leadership

Pharmacy Consulting Group: Expanding Blue’s Services

Blue & Co., LLC is excited to announce it has recently expanded its pharmacy and 340B expertise to meet and exceed the needs of its clients. With the addition of multiple pharmacy staff members in 2020, Blue is positioned to provide a wide array of pharmacy consulting services to healthcare organizations looking for guidance.

About Blue’s Pharmacy Consulting Group

The Pharmacy Consulting Group is a multi-disciplinary team of pharmacy professionals capable of assisting clients with services such as hospital pharmacy operations and finance, pharmacy benefits consulting, retail and specialty pharmacy analysis and implementation assistance, expertise in provider based hospital consulting and expanded 340B assistance.

In order to provide high quality pharmacy consulting for its clients, Blue has added three additional pharmacy subject matter experts with the following specialties:

  • Retail and specialty pharmacy consulting
  • Hospital pharmacy operations and 340B compliance
  • Pharmacy benefits consulting and support

Blue’s healthcare consulting practice continues to be a leader in providing financial auditing and consulting services to clients across many states. With the expansion of the pharmacy team, Blue can now provide excellent pharmacy and 340B consulting services to clients with the same level of expertise as it does with all of its financial services.

Please reach out to one of our Pharmacy Consulting Group members for more information about how we can serve you and your organization.

Share this article

quality of earnings

How a Quality of Earnings Report Protects the Sale of Your Business

By Jonah Gjertson, Senior Consultant at Blue & Co. Preparing to sell your business is a complicated, emotional, and logistically challenging decision with material financial implications. There are many decisions […]

Learn More

MGCRB Reclassification Withdrawal: What Hospitals Need to Know for FY 2027

For hospitals that would like to withdraw an approved Geographic Reclassification, the publishing of the FY 2027 proposed rule starts the 45-day window for withdrawing approved Medicare Geographic Classification Review […]

Learn More

Beyond Compliance: The Strategic Value of Independent External 340B Audits

The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients.  However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]

Learn More